EstechPharma Co. Ltd - Asset Resilience Ratio
EstechPharma Co. Ltd (041910) has an Asset Resilience Ratio of 8.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EstechPharma Co. Ltd (041910) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how EstechPharma Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EstechPharma Co. Ltd balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down EstechPharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of EstechPharma Co. Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩17.12 Billion | 8.74% |
| Total Liquid Assets | ₩17.12 Billion | 8.74% |
Asset Resilience Insights
- Limited Liquidity: EstechPharma Co. Ltd maintains only 8.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EstechPharma Co. Ltd Industry Peers by Asset Resilience Ratio
Compare EstechPharma Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Theragen Etex Co.Ltd
KQ:066700 |
Pharmaceuticals | 0.68% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 6.87% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 65.38% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 13.09% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
|
Caregen Co.Ltd
KQ:214370 |
Pharmaceuticals | 4.58% |
Annual Asset Resilience Ratio for EstechPharma Co. Ltd (2013–2025)
The table below shows the annual Asset Resilience Ratio data for EstechPharma Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.74% | ₩17.12 Billion ≈ $11.60 Million |
₩195.93 Billion ≈ $132.78 Million |
-25.99pp |
| 2024-12-31 | 34.72% | ₩46.68 Billion ≈ $31.64 Million |
₩134.45 Billion ≈ $91.12 Million |
+12.21pp |
| 2023-12-31 | 22.51% | ₩27.44 Billion ≈ $18.60 Million |
₩121.90 Billion ≈ $82.61 Million |
-2.09pp |
| 2022-12-31 | 24.60% | ₩30.58 Billion ≈ $20.72 Million |
₩124.32 Billion ≈ $84.25 Million |
-13.35pp |
| 2021-12-31 | 37.95% | ₩50.98 Billion ≈ $34.55 Million |
₩134.36 Billion ≈ $91.05 Million |
-3.60pp |
| 2020-12-31 | 41.54% | ₩51.16 Billion ≈ $34.67 Million |
₩123.15 Billion ≈ $83.46 Million |
+7.35pp |
| 2019-12-31 | 34.19% | ₩39.81 Billion ≈ $26.98 Million |
₩116.43 Billion ≈ $78.90 Million |
+10.08pp |
| 2018-12-31 | 24.12% | ₩23.72 Billion ≈ $16.07 Million |
₩98.34 Billion ≈ $66.65 Million |
+1.52pp |
| 2017-12-31 | 22.60% | ₩21.46 Billion ≈ $14.54 Million |
₩94.95 Billion ≈ $64.35 Million |
+2.16pp |
| 2016-12-31 | 20.43% | ₩19.92 Billion ≈ $13.50 Million |
₩97.47 Billion ≈ $66.06 Million |
+19.89pp |
| 2015-12-31 | 0.55% | ₩500.00 Million ≈ $338.84K |
₩91.36 Billion ≈ $61.92 Million |
-15.47pp |
| 2014-12-31 | 16.02% | ₩18.35 Billion ≈ $12.43 Million |
₩114.56 Billion ≈ $77.63 Million |
+16.00pp |
| 2013-12-31 | 0.02% | ₩20.00 Million ≈ $13.55K |
₩104.37 Billion ≈ $70.73 Million |
-- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.